Open tender · Germany · Contract notice
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Tafluprost und Timolol (ATC-Code: S01ED70).
AOK Niedersachsen. Die Gesundheitskasse.
AOK Niedersachsen. Die Gesundheitskasse. in Germany is inviting bids for “Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Tafluprost und Timolol…”. Bids close on 26 January 2028. To qualify, bidders need at least one similar completed work.
The work
Conclusion of a non-exclusive discount contract for the drug combination Tafluprost and Timolol (ATC-Code: S01ED70) from 01.04.2026 to 31.03.2028.
- Contract must be a non-exclusive discount contract according to § 130a Abs. 8 SGB V.
- Contract duration is from 01.04.2026 to 31.03.2028.
- Contracts can be concluded at any time during the period ('open-house-Modell').
Key facts
- Contract period
- 24 months
What it takes to qualify
Worth a closer look
- The tender is not a public procurement in the sense of Directive 2014/24/EU.
- The publication is for transparency, not a formal award procedure.
- The exact submission mode and envelope structure are not specified.
Experience
- At least 1 similar work — Experience as a pharmaceutical entrepreneur for the specific drug combination (ATC-Code: S01ED70).
- Experience as a pharmaceutical entrepreneur for the specific drug combination (ATC-Code: S01ED70).
Certifications and registrations
Pharmazeutischer Unternehmer i. S. d. § 4 Abs. 18 AMGMust be a pharmaceutical entrepreneur as defined by § 4 Abs. 18 AMG, with a seat in the AMG area, EU, or EEA.
Pharmazeutischer Unternehmer i. S. d. § 4 Abs. 18 AMG§ 130a Abs. 8 Satz 1 SGB V requires contracts only with pharmaceutical entrepreneurs as defined by § 4 Abs. 18 AMG.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- VertragsunterlagenContract documents must be submitted to AOK Niedersachsen.